Danazol for urinary incontinence in tropical spastic paraparesis
Case report
OA: closed
CC0
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated the efficacy of danazol in treating urinary incontinence in patients diagnosed with tropical spastic paraparesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women 1989
- Danazol: molecular, endocrine, and clinical pharmacology 1990
- Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol 1991
References (7)
- Danazol: molecular, endocrine, and clinical pharmacology via openalex
- Long-term danazol therapy in autoimmune thrombocytopenia: unmaintained remission and age-dependent response in women via openalex
- Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol via openalex
- doi:10.1038/348245a0 via openalex
- W2277231367 via openalex
- doi:10.1016/s0140-6736(85)92734-5 via openalex
- W4285719527 via openalex
Source provenance
- openalex
- last seen: 2026-05-10T10:56:23.235473+00:00
- pubmed
- last seen: 2026-10-08T21:01:29.034871+00:00
License: CC0
· commercial use OK